Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors
Public ClinicalTrials.gov record NCT01392547. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of NNC 0078-0000-0007 in Treatment of Acute Bleeding Episodes in Patients With Congenital Haemophilia and Inhibitors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted globally. The purpose of this trial is to confirm the efficacy and safety of NNC 0078-0000-0007 in patients with congenital haemophilia and inhibitors.
Study identification
- NCT ID
- NCT01392547
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 72 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2011 (Type not available)
- Primary completion
- Aug 2012 (Actual)
- Completion
- Aug 2012 (Actual)
- Last update posted
- May 15, 2017
2011 – 2012
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Clinical Trial Call Center | Tucson | Arizona | 85724-0001 | — |
| Novo Nordisk Clinical Trial Call Center | Los Angeles | California | 90007 | — |
| Novo Nordisk Clinical Trial Call Center | Los Angeles | California | 90027 | — |
| Novo Nordisk Clinical Trial Call Center | Orange | California | 92868 | — |
| Novo Nordisk Clinical Trial Call Center | Aurora | Colorado | 80045 | — |
| Novo Nordisk Clinical Trial Call Center | Tampa | Florida | 33607 | — |
| Novo Nordisk Clinical Trial Call Center | Atlanta | Georgia | 30322 | — |
| Novo Nordisk Clinical Trial Call Center | Augusta | Georgia | 30912 | — |
| Novo Nordisk Clinical Trial Call Center | Iowa City | Iowa | 52242 | — |
| Novo Nordisk Clinical Trial Call Center | Boston | Massachusetts | 02115 | — |
| Novo Nordisk Clinical Trial Call Center | Detroit | Michigan | 48202-2608 | — |
| Novo Nordisk Clinical Trial Call Center | Brooklyn | New York | 11219 | — |
| Novo Nordisk Clinical Trial Call Center | Portland | Oregon | 97239 | — |
| Novo Nordisk Clinical Trial Call Center | Richmond | Virginia | 23219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01392547, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01392547 live on ClinicalTrials.gov.